The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Texas for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Texas’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Territory of the United States Virgin Islands for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 13, 2021 indicated the United State Virgin Islands’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Washington for multiple section 1135 flexibilities on March 19, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Washington’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).